As of 2025-06-15, the Relative Valuation of Coherus BioSciences Inc (CHRS) is (10.12) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.76 USD, the upside of Coherus BioSciences Inc based on Relative Valuation is -1428.9%.
The range of the Relative Valuation is (15.97) - 0.62 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.1x - 23.1x | 18.4x |
| Forward P/E multiples | 16.9x - 28.9x | 22.5x |
| Fair Price | (15.97) - 0.62 | (10.12) |
| Upside | -2196.7% - -19.1% | -1428.9% |
| Date | P/E |
| 2025-06-06 | -0.73 |
| 2025-06-05 | -0.71 |
| 2025-06-04 | -0.71 |
| 2025-06-03 | -0.69 |
| 2025-06-02 | -0.68 |
| 2025-05-30 | -0.69 |
| 2025-05-29 | -0.71 |
| 2025-05-28 | -0.71 |
| 2025-05-27 | -0.69 |
| 2025-05-23 | -0.67 |
| 2025-05-22 | -0.69 |
| 2025-05-21 | -0.68 |
| 2025-05-20 | -0.72 |
| 2025-05-19 | -0.71 |
| 2025-05-16 | -0.67 |
| 2025-05-15 | -0.68 |
| 2025-05-14 | -0.70 |
| 2025-05-13 | -0.73 |
| 2025-05-12 | -0.90 |
| 2025-05-09 | -0.86 |
| 2025-05-08 | -0.88 |
| 2025-05-07 | -0.84 |
| 2025-05-06 | -0.82 |
| 2025-05-05 | -0.90 |
| 2025-05-02 | -0.97 |
| 2025-05-01 | -0.93 |
| 2025-04-30 | -0.91 |
| 2025-04-29 | -0.89 |
| 2025-04-28 | -0.91 |
| 2025-04-25 | -0.91 |
| 2025-04-24 | -0.89 |
| 2025-04-23 | -0.98 |
| 2025-04-22 | -0.97 |
| 2025-04-21 | -0.94 |
| 2025-04-17 | -0.99 |
| 2025-04-16 | -0.89 |
| 2025-04-15 | -0.94 |
| 2025-04-14 | -0.86 |
| 2025-04-11 | -0.74 |
| 2025-04-10 | -0.66 |
| 2025-04-09 | -0.70 |
| 2025-04-08 | -0.68 |
| 2025-04-07 | -0.73 |
| 2025-04-04 | -0.69 |
| 2025-04-03 | -0.72 |
| 2025-04-02 | -0.81 |
| 2025-04-01 | -0.71 |
| 2025-03-31 | -0.71 |
| 2025-03-28 | -0.74 |
| 2025-03-27 | -0.75 |